Loading…
Pharmaceuticals · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0.29% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 0.67% | < 30% | Pass |
| Interest-bearing investments / market cap | 0.24% | < 30% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0.29% of any dividend from GRANULES should be given to charity. Calculate your amount →
GRANULES shows strong, sustained gains over 3–6 months and trades very close to its 52-week high, indicating a robust ongoing uptrend. No sector sentiment given directly affects this read.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.